Related Experiment Video
Updated: Aug 7, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.3K
Patient Outcomes after Introduction of Novel Myocardial Protection Protocol for Prolonged Aortic Cross-Clamping
Masahide Komagamine1, Takuma Fukunishi1, Yoshiki Yamasaki1
1Department of Cardiovascular Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Summary
A revised myocardial protection protocol improved patient outcomes in cardiac surgery requiring prolonged aortic cross-clamping. The new protocol led to lower creatine kinase levels and shorter hospital stays, demonstrating safe and favorable results.
Area of Science:
- Cardiovascular Surgery
- Cardiac Anesthesia
- Myocardial Protection Strategies
Background:
- Cardioplegia is crucial for patient outcomes in cardiac surgery.
- Prolonged aortic cross-clamping presents challenges for myocardial protection.
- Hospital protocol revisions aim to optimize clinical results.
Purpose of the Study:
- To compare clinical outcomes of cardiac surgery patients with prolonged aortic cross-clamping before and after a myocardial protection protocol revision.
- To evaluate the efficacy of a revised protocol in enhancing myocardial protection during extended cross-clamp times.
Main Methods:
- Retrospective study of 36 patients undergoing cardiac surgery with >4h aortic cross-clamping (2018-2024).
- Group 1: Pre-protocol revision (2018-March 2021).
- Group 2: Post-protocol revision (April 2021-2024).
Main Results:
- Group 2 showed significantly lower postoperative creatine kinase levels (P=0.018).
- Group 2 experienced a significantly shorter hospital stay (P=0.017).
- No statistically significant difference in new postoperative right-ventricular dysfunction between groups.
Conclusions:
- The revised myocardial protection protocol is safe and effective for cardiac surgeries with prolonged aortic cross-clamping.
- The protocol achieves favorable surgical results without altering the cardioplegia solution.
- Optimized myocardial protection strategies can improve patient recovery post-cardiac surgery.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...